HOME >> BIOLOGY >> NEWS
'Sperm and germ'-fighting contraceptive enters trials

rm and germs, it must do so without hurting the friendly bacteria in a healthy vagina, like the lactobacilli, he explains. Also, it mustnt smell bad or taste bad or stain the sheets. And most importantly, it mustnt irritate sensitive vaginal tissues. BufferGel has met those standards both in animal trials and in extensive clinical safety trials, according to Cone.

For the new contraceptive efficacy trial, researchers at 10 sites in the United States are enrolling 1,000 women. Participants must be in a sexually active and monogamous relationship and at low risk for infection by sexually transmitted diseases. They must agree not to use other forms of contraception beyond that supplied by the study, and be willing to risk getting pregnant. Study participants will use a diaphragm with either BufferGel or a conventional spermicide.

In this trial, we want to achieve the highest possible level of protection, says Thomas Moench, medical director for ReProtect LLC. Were including a diaphragm because it places a discrete physical barrier over the cervix, significantly enhancing the protective actions of contraceptive microbicides.

Moench, formerly an assistant professor of infectious diseases at the Johns Hopkins Medical Institutions, originally created BufferGel with Cone. Hopkins and ReProtect LLC are developing BufferGel through a cooperative research agreement.

Researchers are also currently planning a larger trial to test BufferGels ability to block transmission of HIV and genital herpes. The trial is scheduled to take place through NIHs HIV Prevention Trials Network next year.


'"/>

Contact: Michael Purdy
mcp@jhu.edu
410-516-7906
Johns Hopkins University
3-Jan-2002


Page: 1 2

Related biology news :

1. Synthetic hormone used in contraceptives and HRT produces negative effects in monkey studies
2. UT Southwestern researchers discovery may lead to gene targets for new form of contraceptive
3. Oral contraceptives increase C-reactive protein, an infIammatory biomarker
4. The contraceptive plague
5. Newly found estrogen role in males might lead to contraceptive for men
6. New study shows oral contraceptive may be effective in treating severe form of premenstrual syndrome
7. Berlex Laboratories announces FDA approval of YASMIN (R), new oral contraceptive with unique progestin
8. Study suggests newer oral contraceptives may be less harmful for women smokers
9. NHGRI launches Centers for Excellence in Ethical, Legal, and Social Implications Research
10. Images reveal how rotavirus - leading cause of diarrhea - enters cells
11. Proteomic research centers target bioterrorism agents, infectious diseases

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2017)... , April 13, 2017 According to a new ... Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, ... IAM Market is expected to grow from USD 14.30 Billion in 2017 ... (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... INDIANAPOLIS , Oct. 11, 2017  VMS BioMarketing, a ... of a nationwide oncology Clinical Nurse Educator (CNE) network, which ... growing need for communication among health care professionals to enhance ... physicians, nurses, office staff, and other health care professionals to ... for breast cancer. ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced that ... SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 ... cross the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... Dr. Bob ... at his local San Diego Rotary Club. The event entitled “Stem ... CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two ...
(Date:10/10/2017)... ... 10, 2017 , ... The Pittcon Program Committee is pleased ... scientists who have made outstanding contributions to analytical chemistry and applied spectroscopy. Each ... leading conference and exposition for laboratory science, which will be held February 26-March ...
Breaking Biology Technology:
Cached News: